Mohamed Genead
Amministratore Delegato presso Aviceda Therapeutics, Inc.
Profilo
Mohamed A.
Genead is the founder of Aviceda Therapeutics, Inc. He is currently the Chairman, President & Chief Executive Officer of Aviceda Ophthalmics, Inc. He was previously the Director-Center of Retina Degenerative Diseases at the University of Illinois and the Chief Medical Officer at Ocugen, Inc. In 2017, he briefly served as the Chief Medical Officer at Gensight Biologics SA.
Posizioni attive di Mohamed Genead
Società | Posizione | Inizio |
---|---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Amministratore Delegato | - |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Amministratore Delegato | - |
Precedenti posizioni note di Mohamed Genead
Società | Posizione | Fine |
---|---|---|
GENSIGHT BIOLOGICS S.A. | Direttore Tecnico/Scientifico/R&S | 01/11/2017 |
University of Illinois | Corporate Officer/Principal | - |
OCUGEN, INC. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
GENSIGHT BIOLOGICS S.A. | Health Technology |
OCUGEN, INC. | Health Technology |
Aziende private | 2 |
---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Commercial Services |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Health Technology |
- Borsa valori
- Insiders
- Mohamed Genead